Company / Profit Margin
ANAPTYSBIO, INC Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-5.6%
FY2025
5-year range
-1216.7% / -5.6%
FY2021-FY2025
Trend
+96.5%
vs FY2024
Sector context
#69 of 146
Health Care
What the data says
At -5.6%, ANAPTYSBIO, INC's profit margin ranks #69 of 146 in the Health Care sector. Profit Margin has fluctuated over the past 9 years, ranging from -1233.1% in FY2020 to -5.6% in FY2025.
Based on SEC 10-K filings.
-5.6% in FY2025 with a 5-year CAGR of +1227.5%.
Improved from -953.7% to -5.6% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +20.9pp
- 5-Year Change
- +1227.5pp
- 10-Year Change
- -
Sector benchmark
#69 of 146 in Health CareTop 47% of 146This company -5.6% Sector average -796.3%
▼
+99.3% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 96.5% year-over-year.
- Currently 790.6pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -5.6% | +96.5% |
| FY2024 | -159.1% | +83.3% |
| FY2023 | -953.7% | -3489.2% |
| FY2022 | -26.6% | +97.8% |
| FY2021 | -1216.7% | +1.3% |
| FY2020 | -1233.1% | -310.1% |
| FY2019 | -300.7% | - |
| FY2018 | - | - |
| FY2017 | -30.8% | -20.5% |
| FY2016 | -25.5% | +17.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026